VIRPAX PHARMACEUTICALS INC - COM (VRPX)

CUSIP: 928251107

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / COM
Total 13F shares
377,134
Share change
-240,040
Total reported value
$120,538
Price per share
$0.32
Number of holders
17
Value change
-$217,741
Number of buys
10
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 928251107?
CUSIP 928251107 identifies VRPX - VIRPAX PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of VIRPAX PHARMACEUTICALS INC - COM (VRPX) as of Q4 2023

As of 31 Dec 2023, VIRPAX PHARMACEUTICALS INC - COM (VRPX) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 377,134 shares. The largest 10 holders included PNC FINANCIAL SERVICES GROUP, INC., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, SHEETS SMITH WEALTH MANAGEMENT, RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, NORTHERN TRUST CORP, TWO SIGMA SECURITIES, LLC, UBS Group AG, and Tower Research Capital LLC (TRC). This page lists 17 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.